Antiviral Therapy in Patients with Hepatitis C Virus-Induced Cirrhosis

Publisher： Karger

E-ISSN： 1421-9875|33|4|613-623

ISSN： 0257-2753

Source： Digestive Diseases, Vol.33, Iss.4, 2015-07, pp. : 613-623

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation

By Forns X. Garcia-Retortillo M. Serrano T. Feliu A. Suarez F. de la Mata M. Garcia-Valdecasas J.C. Navasa M. Rimola A. Rodes J.

Journal of Hepatology, Vol. 39, Iss. 3, 2003-09 ,pp. : 389-396

Elsevier

Access to resources Recommend Favorite

Antiviral Therapy in Hepatitis B Virus-Associated Liver Cirrhosis

Digestive Diseases, Vol. 33, Iss. 4, 2015-07 ,pp. : 608-612

Karger

Access to resources Recommend Favorite

Hepatitis C Virus-Induced Steatosis: An Overview

Digestive Diseases, Vol. 28, Iss. 1, 2010-05 ,pp. : 294-299

Karger

Access to resources Recommend Favorite

Efficacy and safety of 6-month iron reduction therapy in patients with hepatitis C virus-related cirrhosis: a pilot study

By Tanaka Naoki Horiuchi Akira Yamaura Takahiro Komatsu Michiharu Tanaka Eiji Kiyosawa Kendo

Journal of Gastroenterology, Vol. 42, Iss. 1, 2007-01 ,pp. : 49-55

Springer Publishing Company

Access to resources Recommend Favorite

Pegylated interferon and ribavirin combination therapy for chronic hepatitis C virus infection in patients with Child-Pugh Class A liver cirrhosis

By Syed Eliya Rahbin Nogol Weiland Ola Carlsson Tony Oksanen Antti Birk Markus Davidsdottir Loa Hagen Karin Hultcrantz Rolf Aleman Soo

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 11, 2008-01 ,pp. : 1378-1386

Informa Healthcare

Access to resources Recommend Favorite